Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.
Conditions:   COVID-19;   Deep Vein Thrombosis;   Anticoagulants and Bleeding Disorders;   Critical Illness Interventions:   Drug: Enoxaparin;   Drug: Heparin Sponsor:   University Hospital, Ghent Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2022 Category: Research Source Type: clinical trials

Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilization Treatment
Conditions:   Infertility, Female;   Thrombophilia;   Fertilization in Vitro Intervention:   Drug: Enoxaparin Sponsor:   Faculdade de Medicina do ABC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2022 Category: Research Source Type: clinical trials

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.
Conditions:   COVID-19;   Deep Vein Thrombosis;   Anticoagulants and Bleeding Disorders;   Critical Illness Interventions:   Drug: Enoxaparin;   Drug: Heparin Sponsor:   University Hospital, Ghent Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2022 Category: Research Source Type: clinical trials

Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilization Treatment
Conditions:   Infertility, Female;   Thrombophilia;   Fertilization in Vitro Intervention:   Drug: Enoxaparin Sponsor:   Faculdade de Medicina do ABC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2022 Category: Research Source Type: clinical trials

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.
Conditions:   COVID-19;   Deep Vein Thrombosis;   Anticoagulants and Bleeding Disorders;   Critical Illness Interventions:   Drug: Enoxaparin;   Drug: Heparin Sponsor:   University Hospital, Ghent Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2022 Category: Research Source Type: clinical trials

Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilization Treatment
Conditions:   Infertility, Female;   Thrombophilia;   Fertilization in Vitro Intervention:   Drug: Enoxaparin Sponsor:   Faculdade de Medicina do ABC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2022 Category: Research Source Type: clinical trials

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.
Conditions:   COVID-19;   Deep Vein Thrombosis;   Anticoagulants and Bleeding Disorders;   Critical Illness Interventions:   Drug: Enoxaparin;   Drug: Heparin Sponsor:   University Hospital, Ghent Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2022 Category: Research Source Type: clinical trials

Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilization Treatment
Conditions:   Infertility, Female;   Thrombophilia;   Fertilization in Vitro Intervention:   Drug: Enoxaparin Sponsor:   Faculdade de Medicina do ABC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2022 Category: Research Source Type: clinical trials

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.
Conditions:   COVID-19;   Deep Vein Thrombosis;   Anticoagulants and Bleeding Disorders;   Critical Illness Interventions:   Drug: Enoxaparin;   Drug: Heparin Sponsor:   University Hospital, Ghent Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2022 Category: Research Source Type: clinical trials